公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1996 | Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid. | Chou, WC; Su, IJ; Tien, HF; Liang, DC; Wang, CH; Chang, YC; Cheng, AL. | Cancer | | | |
2008 | Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: need for a revisit of surgical treatment. | Kuo, SH; Chen, LT; Wu, MS; Lin, CW; Yeh, KH; Kuo, KT; Yeh, PY; Tzeng, YS; Wang, HP; Hsu, PN; Lin, JT; Cheng, AL. | Ann Surg | | | |
2004 | Nuclear expression of Bcl-10 or NF-kappaB predicts Helicobacter pylori-independent status of early-stage high-grade gastric MALT lymphomas. | Kuo, SH; Chen, LT; Kun-Huei, Yeh; Wu, MS; Hsu, HC; Yeh, PY; Mao, TL; Chen, CL; Doong, SL; Lin, JT; Cheng, AL. | J Clin Oncol 2004; | | | |
2006 | A pathway for TNFalpha -induced Bcl10 nuclear translocation: Bcl10 is upregulated by NFkappa B, phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. | Yeh, PY; Kuo, SH; Yeh, KH; Chuang, SE; Hsu, CH; Chang, WC; Lin, HI; Gao, M; Cheng, AL. | J Biol Chem | | | |
2004 | Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma. | Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. | Hepatogastroenterology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |
2004 | Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr-dephosphorylation. | Yeh, PY; Kun-Huei, Yeh; Chuang, SE; Song, YC; Cheng, AL. | J Biol Chem 2004; | | | |